During the fetal stage, a number of so-called cell programs run that are vital to the development of the fetus. In a study published in Cell Reports, researchers from Lund University demonstrate that one of these fetal programs appears to protect against acute myeloid leukemia (AML).
“We have used an experimental mouse model that always results in this type of leukemia. The interesting thing is that, when we added to adult mice a specific molecular cell program that normally only runs during fetal development, over half did not develop AML,” says David Bryder, professor of experimental hematology at Lund University.
The fetal program that the researchers used consists of the RNA-binding protein LIN28, the normal function of which is to regulate other genes. LIN28 is usually only expressed during fetal development and disappears shortly after birth.

.jpg)


.jpg)

.jpg)

